High Vista Strategies LLC Cerevel Therapeutics Holdings, Inc. Transaction History

High Vista Strategies LLC

  • $242 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$20.27 - $42.44 $1.47 Million - $3.07 Million
72,313 Added 290.57%
97,200 $4.12 Million
Q3 2023

Nov 14, 2023
BUY
$20.26 - $31.91 $504,210 - $794,144
24,887 New
24,887 $543,000
Q3 2022

Nov 14, 2022
SELL
$25.5 - $41.42 $123,394 - $200,431
-4,839 Reduced 17.01%
23,611 $667,000
Q2 2022

Aug 15, 2022
BUY
$20.62 - $37.15 $586,639 - $1.06 Million
28,450 New
28,450 $752,000

Others Institutions Holding CERE

# of Institutions
7
Shares Held
5.01M
Call Options Held
3.3K
Put Options Held
0
View Full List

About Cerevel Therapeutics Holdings, Inc.

CERE Quotes by TradingView
  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email